Literature DB >> 22778318

Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.

Robert A Ramirez1, Christopher G Wang, Laura E Miller, Courtney A Adair, Allen Berry, Xinhua Yu, Thomas F O'Brien, Raymond U Osarogiagbon.   

Abstract

PURPOSE: Pathologic nodal stage affects prognosis in patients with surgically resected non-small-cell lung cancer (NSCLC). Unlike examination of mediastinal lymph nodes (LNs), which depends on surgical practice, accurate examination of intrapulmonary (N1) nodes depends primarily on pathology practice. We investigated the completeness of N1 LN examination in NSCLC resection specimens and its potential impact on stage. PATIENTS AND METHODS: We performed a case-control study of a special pathologic examination (SPE) protocol using thin gross dissection with retrieval and microscopic examination of all LN-like material on remnant NSCLC resection specimens after routine pathologic examination (RPE). We compared LNs retrieved by the SPE protocol with nodes examined after RPE of the same lung specimens and with those of an external control cohort.
RESULTS: We retrieved additional LNs in 66 (90%) of 73 patient cases and discovered metastasis in 56 (11%) of 514 retrieved LNs from 27% of all patients. We found unexpected LN metastasis in six (12%) of 50 node-negative patients. Three other patients had undetected satellite metastatic nodules. Pathologic stage was upgraded in eight (11%) of 73 patients. The time required for the SPE protocol decreased significantly with experience, with no change in the number of LNs found.
CONCLUSION: Standard pathology practice frequently leaves large numbers of N1 LNs unexamined, a clinically significant proportion of which harbor metastasis. By improving N1 LN examination, SPE can have an impact on prognosis and adjuvant management. We suggest adoption of the SPE to improve pathologic staging of resected NSCLC.

Entities:  

Mesh:

Year:  2012        PMID: 22778318     DOI: 10.1200/JCO.2011.39.2589

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  47 in total

1.  Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk model.

Authors:  Ulas Kumbasar; Hilgardt Raubenheimer; May Al Sahaf; Nizar Asadi; Maria Elena Cufari; Chiara Proli; Periklis Perikleous; Zakiyah Niwaz; Emma Beddow; Vladimir Anikin; Niall McGonigle; Simon Jordan; George Ladas; Michael Dusmet; Eric Lim
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Response to: intrapulmonary lymph node retrieval.

Authors:  Christina Brzezniak; Giuseppe Giaccone
Journal:  Transl Lung Cancer Res       Date:  2013-04

3.  Response to editorial titled 'Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection'.

Authors:  Raymond U Osarogiagbon; Laura E Miller; Christopher G Wang; Robert A Ramirez
Journal:  Transl Lung Cancer Res       Date:  2013-04

4.  Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection.

Authors:  Christina Brzezniak; Giuseppe Giaccone
Journal:  Transl Lung Cancer Res       Date:  2012-12

Review 5.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

6.  The "N"-factor in non-small cell lung cancer: staging system and institutional reports.

Authors:  Ottavio Rena
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Improving post-resection risk stratification in non-small cell lung cancer: 'wit, whither wander you?'

Authors:  Raymond U Osarogiagbon
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

8.  Can mathematics replace anatomy to establish recommendations in lung cancer surgery?

Authors:  Marc Riquet; Ciprian Pricopi; Antoine Legras; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 9.  Measuring improvement in populations: implementing and evaluating successful change in lung cancer care.

Authors:  Xinhua Yu; Lisa M Klesges; Mathew P Smeltzer; Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.